Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2018-06-15 Regulatory Filings
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2018
Regulatory Filings
2018-06-15 English
8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The key content is under Item 3.01, which discusses a Notice of Delisting or Failure to Satisfy a Continued Listing Rule due to the company's stock price falling below the minimum bid price requirement of $1.00 per share on Nasdaq. The document is relatively short (3589 characters) and focuses on the notification of non-compliance with listing standards and the potential delisting timeline. This matches the definition of a Delisting Announcement (DLST), which is an official notice that the company's stock will be removed from an exchange or is at risk of removal. Therefore, the correct classification is DLST with high confidence.
2018-06-01 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into and termination of a material definitive agreement related to the commercialization and clinical development rights of a product, including financial terms and transition services. It includes exhibits such as the agreement and a press release. This type of filing is a regulatory announcement of a significant corporate event, not a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is 4072 characters, which is typical for an 8-K filing. No financial statements or detailed financial analysis are included, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a Management or Board change announcement, nor a capital or financing update. Hence, the classification is RNS with high confidence.
2018-05-30 English
FORM 3
Director's Dealing
2018-05-23 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes the appointment of a new board member and amendments to a rights agreement related to a loan and equity conversion rights. The key section is Item 5.02, which deals with the departure or appointment of directors or officers. This matches the description of Board/Management Information filings, which announce changes in the company's board of directors or senior management. The document is not a full annual or quarterly report, nor is it an earnings release or other financial report. It is also not a proxy statement or voting results announcement. Therefore, the correct classification is MANG (Board/Management Information). The confidence in this classification is high given the clear content and form type.
2018-05-16 English
10-Q
Interim / Quarterly Report Q1 2018
2018-05-15 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.